Search for: "Bio-Rad Laboratories, Inc."
Results 1 - 20
of 35
Sort by Relevance
|
Sort by Date
19 Jul 2022, 6:33 am
Bio-Rad Laboratories, Inc. in which it stated that “Congress uses the phrase 'any rule or regulation of the [SEC]' in the same list in which it uses 'any provision of Federal law relating to fraud against shareholders,' which strongly suggests that there is a difference between the meaning of 'rule or regulation' and 'law.'” The First Circuit added that Baker’s interpretation of the phrase “rule or… [read post]
13 Dec 2021, 1:40 pm
Court of Appeals for the Federal Circuit, May 28, 2021, Bio-Rad Laboratories, Inc. v. [read post]
7 Jul 2021, 6:39 am
I have been following the patent ownership lawsuit of Bio-Rad Laboratories, Inc. v. [read post]
2 Jun 2021, 9:58 pm
International Trade Commission. (10X Genomyx obtained a similar exclusion order against Bio-Rad in a case appealed last month; see "Bio-Rad Laboratories, Inc. v. [read post]
19 May 2021, 9:59 pm
Noonan -- Last month, the Federal Circuit affirmed an exclusion order imposed by the International Trade Commission against Bio-Rad for importing infringing microfluidic systems and components used for gene sequencing or related analyses, in Bio-Rad Laboratories, Inc. v. [read post]
3 May 2021, 9:15 am
Court of Appeals for the Federal Circuit (CAFC) affirmed an International Trade Commission (ITC) decision in Bio-Rad Laboratories v. [read post]
3 May 2021, 9:15 am
International Trade Commission & 10X Genomics, Inc. finding that Bio-Rad infringed the patent claims at issue; that 10X Genomics (10X) practiced the claims; and rejecting Bio-Rad’s defense that it could not be liable for infringement because it co-owned the asserted 10X patents. 10X filed a complaint against Bio-Rad Laboratories with the... [read post]
10 Dec 2020, 2:46 pm
Specifically, during the pendency of the litigation, nonparty Bio-Rad Laboratories had acquired 100 percent of Defendant Celsee, Inc. [read post]
10 Dec 2020, 2:46 pm
Specifically, during the pendency of the litigation, nonparty Bio-Rad Laboratories had acquired 100 percent of Defendant Celsee, Inc. [read post]
4 Nov 2020, 7:17 am
by Dennis Crouch Bio-Rad Laboratories, Inc. v. 10X Genomics Inc., 19-2255 (Fed. [read post]
25 Aug 2020, 2:06 am
The Federal Circuit decision in Bio-Rad Laboratories, Inc. v. 10X Genomics Inc., addresses several interesting issues. [read post]
2 May 2019, 9:43 pm
By Donald Zuhn -- Last month, in Bio-Rad Laboratories, Inc. v. 10X Genomics, Inc., District Judge Richard G. [read post]
9 Apr 2019, 9:56 am
Andrews in Bio-Rad Laboratories, Inc. v. 10X Genomics, Inc., Civil Action No. 18-1679-RGA (D.Del. [read post]
5 Mar 2019, 8:50 am
Bio-Rad Laboratories, Inc., No. 17-16193, 2019 WL 924827 (9th Cir. [read post]
4 Mar 2019, 4:39 pm
Bio-Rad Laboratories, Inc., No. 17-16193, 2019 WL 924827 (9th Cir. [read post]
4 Mar 2019, 4:39 pm
Bio-Rad Laboratories, Inc., No. 17-16193, 2019 WL 924827 (9th Cir. [read post]
17 Jan 2019, 12:57 pm
Arista Networks, Inc.; Autodesk, Inc.; BioMarin Pharmaceutical Inc.; Bio-Rad Laboratories, Inc.; Cadence Design Systems, Inc.; Cisco Systems, Inc.; Citrix Systems, Inc.; Dell Technologies; Dolby Laboratories Inc.; eBay Inc.; Equinix, Inc.; Electronic Arts Inc.; Facebook, Inc.; FireEye, Inc.; Fortinet, Inc.; GoPro, Inc.; Guidewire… [read post]
3 Nov 2018, 3:47 am
Andrews in Bio-Rad Laboratories, Inc. et al. v. 10X Genomics, Inc., Civil Action No. 15-152-RGA (D.Del. [read post]
13 Aug 2017, 12:54 am
Finally, in Bio-Rad Laboratories, Inc. [2017] APO 38, an examiner’s objections against claims directed to a method of establishing a statistically valid assay mean and assay range for a particular lot of a quality control material were upheld by the Hearing Officer, although Bio-Rad has been provided with an opportunity to amend its application to try to overcome the objections.I am not particularly surprised by the outcomes in Todd… [read post]
5 Jul 2017, 9:30 pm
Petitioners Myriad Genetics, Inc.; Myriad Genetic Laboratories, Inc.; Bio-Rad Laboratories, Inc.; and RainDance Technologies, Inc. are challenging the '706 patent on six grounds as being anticipated under 35 U.S.C. [read post]
